How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bleeding Toothpastes Market
- By Product Type: Herbal Bleeding Toothpaste, Fluoride Bleeding Toothpaste, Antibacterial Bleeding Toothpaste, Whitening Bleeding Toothpaste, Sensitivity Relief Bleeding Toothpaste
- By Formulation: Gel, Paste, Powder
- By Target Consumer: Adults, Children, Seniors
- By Distribution Channel: Supermarkets/Hypermarkets, Pharmacies/Drugstores, Online Retail, Specialty Stores
- By Price Range: Economy, Mid-Range, Premium
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Herbal Bleeding Toothpaste leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Bleeding Toothpastes Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Formulation 3
Target Consumer 3
Distribution Channel 4
Price Range 3
Companies profiled
Colgate-Palmolive Company
GlaxoSmithKline plc (Sensodyne)
Procter & Gamble (Crest)
Unilever
Johnson & Johnson (Listerine)
Dabur India Ltd.
Himalaya Drug Company
Church & Dwight Co.
Inc. (Arm & Hammer)
Cipla Ltd.
Dr. Fresh Inc.
Marico Limited
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Colgate-Palmolive Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GlaxoSmithKline plc (Sensodyne)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Procter & Gamble (Crest)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Unilever
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Johnson & Johnson (Listerine)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Dabur India Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Himalaya Drug Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Church & Dwight Co.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Inc. (Arm & Hammer)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Cipla Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Dr. Fresh Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Marico Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Patanjali Ayurved Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Reckitt Benckiser Group plc (Dettol)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Sunstar Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Lion Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →
Global · 2025–2033
$3,509M by 2033 · 11.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Herbal Bleeding Toothpaste35.9
- Fluoride Bleeding Toothpaste19.3
- Antibacterial Bleeding Toothpaste15.8
- Whitening Bleeding Toothpaste16.2
- Sensitivity Relief Bleeding Toothpaste12.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$490.9M → $1,072M · 10.3%
Europe$342.2M → $804.0M · 11.3%
Asia Pacific$312.4M → $692.5M · 10.5%
Latin America$193.4M → $495.6M · 12.5%
Middle East and Africa$148.8M → $332.2M · 10.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.272026
11.282027
11.302028
11.312029
11.322030
11.332031
11.362032
11.352033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Colgate-Palmolive Company25.3
- GlaxoSmithKline plc (Sensodyne)20.5
- Procter & Gamble (Crest)6.6
- Unilever4.7
- Johnson & Johnson (Listerine)9.3
- Dabur India Ltd.5.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type23.1%
Formulation26.3%
Target Consumer18.5%
Distribution Channel23.1%
Price Range9.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.6
- Europe23.7
- Asia Pacific20.4
- Latin America14.6
- Middle East and Africa9.8
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Colgate-Palmolive Company | 96 | 83 | 88 | 75 | 93 | 80 | 86 |
| GlaxoSmithKline plc (Sensodyne) | 93 | 72 | 79 | 80 | 69 | 71 | 77 |
| Procter & Gamble (Crest) | 78 | 81 | 68 | 69 | 84 | 80 | 77 |
| Unilever | 79 | 74 | 61 | 62 | 75 | 71 | 70 |
| Johnson & Johnson (Listerine) | 67 | 76 | 55 | 61 | 66 | 53 | 63 |
| Dabur India Ltd. | 50 | 63 | 55 | 61 | 66 | 53 | 58 |
| Himalaya Drug Company | 52 | 57 | 56 | 61 | 66 | 44 | 56 |
| Church & Dwight Co. | 45 | 48 | 57 | 52 | 40 | 44 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Colgate-Palmolive Company
- GlaxoSmithKline plc (Sensodyne)
- Procter & Gamble (Crest)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Colgate-Palmolive Company | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| GlaxoSmithKline plc (Sensodyne) | ✓ | − | ◐ | ✓ | ✓ | ✓ |
| Procter & Gamble (Crest) | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Unilever | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Johnson & Johnson (Listerine) | ◐ | ✓ | ◐ | − | ✓ | − |
| Dabur India Ltd. | − | ◐ | ◐ | − | − | ◐ |
| Himalaya Drug Company | ◐ | − | − | ◐ | ◐ | − |
| Church & Dwight Co. | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Colgate-Palmolive Company86
2GlaxoSmithKline plc (Sensodyne)77
3Procter & Gamble (Crest)77
4Unilever70
5Johnson & Johnson (Listerine)63
6Dabur India Ltd.58
7Himalaya Drug Company56
8Church & Dwight Co.48
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Colgate-Palmolive Company
Challenger3
Strong scale, closing on the leaders.
GlaxoSmithKline plc (Sensodyne)Procter & Gamble (Crest)Unilever
Contender2
Focused players with pockets of strength.
Johnson & Johnson (Listerine)Dabur India Ltd.
Niche2
Specialists in a single segment or region.
Himalaya Drug CompanyChurch & Dwight Co.
Go-to-market strategy
Land Product Type in North America, then scale across Bleeding Toothpastes Market — a $269M beachhead inside a $3.58B market.
Beachhead (SOM)$269Mobtainable near-term
Serviceable (SAM)$1.46Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Herbal Bleeding Toothpaste
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Fluoride Bleeding Toothpaste
Strong fit — clear ROI and a fast path to value.
End user69 fit
Antibacterial Bleeding Toothpaste
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Consumer
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel25%
Digital / self-serve17%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bleeding Toothpastes Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified25%
Evaluation13%
Closed-won6%
$14.0KCAC
$52KLTV
3.7:1LTV : CAC
< 5 moCAC payback
Investment thesis
Bleeding Toothpastes Market is a durable-growth opportunity — $9.21B by 2033, compounding at 9.3%.
TAM · 2025$4.52Btoday
TAM · 2033$9.21Bforecast
CAGR9.3%2027–2033
Cumulative$59.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.21BTotal addressable market
SAM$3.46BServiceable available market
SOM$628MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.21BLarge & growingTAM by 2033 at 9.3% CAGR
$3.46BServiceable nowreachable with today’s model
$628MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.18BBear6.0% CAGR
$9.21BBase9.3% CAGR
$11.8BBull12.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bleeding Toothpastes Market — a $612M market by 2033. Plan: grow share from 9.1% to 16.5%.
Market size · 2033$612Mtotal addressable
Market CAGR3.3%2027–2033
Target share16.5%from 9.1% today
Revenue ambition$101Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.1% | 16.5% | At risk |
| Revenue | $60M | $101M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 29.5% | 44.4% | Behind |
| Customer retention | 87.6% | 95.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation capability
A defensible second engine — invest in Formulation to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $13M capacity & capability investment
- Greenlight bolt-on M&A in Formulation
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Bleeding Toothpastes Market conversation — a $1.67B market you can size, segment and defend in minutes.
Market size · 2033$1.67Btotal opportunity
Growth8.3%CAGR to 2033
Addressable buyers1,313+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 2 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Colgate-Palmolive CompanyGlaxoSmithKline plc (Sensodyne)Procter & Gamble (Crest)UnileverJohnson & Johnson (Listerine)Dabur India Ltd.Himalaya Drug CompanyChurch & Dwight Co.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bleeding Toothpastes Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bleeding Toothpastes Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blemish Balm (Bb) And Color Correction (Cc) Products Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportBlended & Prepared Flour, Flour Mixes Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportBlended Edible Olive Oil Market
Market size, share, segmentation and regional forecast.
$606M market · 2025 base year
View reportBlended Fabric Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportBlended Learning Courses Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportBlended Mustard Powder Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBlended Polyphenylene Ether Alloy Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportBlended Yarn Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportBlender Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBlender Mixer Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBlending Machine Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportBlending PVC Resin Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.